|
Dr. Zhang Luyong is the Chief Technology Officer (CTO) of China Biopharmaceutical Holdings (CBH). He is also a professor and Deputy Director of the technology department of China Pharmaceutical University and a consultant to the National Drugs Examination Committee of China Food and Drug Administration (SFDA). Mr. Zhang founded and was the head of Xinzhung Drug Research and Development Center. He also served as the head of the department of New Drug Examination at China Food and Drug Administration (SFDA) and in this capacity, was invited to lead numerous research projects which were funded by both the government and the private sector. For example, he led the National Laboratory of New Drugs Screening project and established the first national class laboratory in China to be approved by the Ministry of Technology. He also founded Jiangsu New Drugs Screening Center with funding from Jiangsu Province government. Mr. Zhang graduated from China Pharmaceutical University in 1983 with a B.S. degree in Pharmacology and graduated from China Pharmaceutical University in 1989 with a Ph.D. in Pharmacology. He currently holds a professorship at China Pharmaceutical University. | 